|
Volumn 23, Issue 3-4, 2001, Pages 98-106
|
Rett syndrome: Clinical characteristics and recent genetic advances
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMMONIA;
BINDING PROTEIN;
CARNITINE;
MAGNESIUM;
MELATONIN;
PLACEBO;
ARTICLE;
CHILD;
CHROMOSOME XP;
CHROMOSOME XQ;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CPG ISLAND;
DEVELOPMENTAL DISORDER;
DIFFERENTIAL DIAGNOSIS;
DISEASE SEVERITY;
DOWN SYNDROME;
FEMALE;
GENDER;
GENE MUTATION;
HISTORY;
HUMAN;
HYPERAMMONEMIA;
HYPERVENTILATION;
INFANT;
MENTAL DEFICIENCY;
MOLECULAR GENETICS;
PHENOTYPE;
PRIORITY JOURNAL;
RETT SYNDROME;
SEIZURE;
X CHROMOSOME LINKAGE;
AGE OF ONSET;
CHROMOSOMAL PROTEINS, NON-HISTONE;
DIAGNOSIS, DIFFERENTIAL;
DISEASE PROGRESSION;
DNA-BINDING PROTEINS;
HUMANS;
LINKAGE (GENETICS);
METHYL-CPG-BINDING PROTEIN 2;
MOLECULAR BIOLOGY;
MUTATION;
NEUROCHEMISTRY;
PATIENT CARE TEAM;
PHENOTYPE;
REPRESSOR PROTEINS;
RETT SYNDROME;
SEX DISTRIBUTION;
X CHROMOSOME;
|
EID: 0035836010
PISSN: 09638288
EISSN: None
Source Type: Journal
DOI: 10.1080/09638280150504171 Document Type: Article |
Times cited : (67)
|
References (96)
|